Skip to main content
Log in

Reduction in Opiate Use, Pain, Nausea, and Length of Stay After Implementation of a Bariatric Enhanced Recovery After Surgery Protocol

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Purpose

Evaluate adherence to bariatric surgery enhanced recovery after surgery (ERAS) protocols in pre-operative, operative, and post-operative phases, and to compare opiate use, nausea control, and length of stay (LOS) versus historical controls.

Materials and Methods

A retrospective, observational cohort study was conducted to evaluate adherence to ERAS protocols and compare opiate and antiemetic use, pain intensity, and LOS versus those of traditional care (TC) patients preceding protocol implementation at Erie County Medical Center, a community-based hospital in Buffalo, NY, USA.

Results

One hundred ERAS and TC patients were compared. Patients were similar in age (42.5 years), gender (female, ~ 80%), race (~ 80 white), and BMI (47 kg/m2). The primary procedure performed was sleeve gastrectomy (89% ERAS, 86% TC). Protocol adherence was high for ERAS phases: prior to admission (85–98%), pre-operative (96–100%), operative (93–99%), post-anesthesia care unit (PACU) (55–61%), and floor (86–98%). Opiate morphine milligram equivalent (MME) was reduced in ERAS vs. TC in hospital by 73% (43.5 ± 42.4 vs. 160 ± 116; p < 0.001), discharge prescribing by 53% (34.8 ± 38.2 vs. 74 ± 125 MME; p = 0.003), and in total by 69% (78.3 ± 67.5 vs. 252 ± 160; p < 0.001). Despite lower opiate use, ERAS had lower pain intensity entering PACU (1.1 ± 1.8 vs. 1.9 ± 2.6; p < 0.011), leaving PACU (1.7 ± 1.5 vs. 2.9 ± 1.5; p < 0.001), and floor day 0 (5.0 ± 2.1 vs. 5.9 ± 1.8; p < 0.001). Fewer ERAS required antiemetic day 0 (63% vs. 94%; p < 0.001). ERAS were discharged in fewer hours than TC (41.1 ± 15.5 vs. 52.1 ± 18.9 h; p < 0.001).

Conclusions

Bariatric surgery ERAS protocols were implemented with a high rate of adherence and yielded profound reduction in operative and post-operative opiate use while improving pain control and nausea management in hospital and decreasing LOS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Flegal KM, Carroll MD, Kuczmarski RJ, et al. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord. 1998:39–47.

  2. Davis S, Babidge W, Kiermeier A, et al. Perioperative mortality following bariatric surgery in Australia. Obes Surg. 2018;28(5):1329–34.

    Article  Google Scholar 

  3. American Society of Bariatric and Metabolic Surgery. Estimate of bariatric surgery numbers, 2011-2018. Available at: https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers. Accessed 31 Dec 2020.

  4. Meunier H, Le Roux Y, Fiant A-L, et al. Does the implementation of enhanced recovery after surgery (ERAS) guidelines improve outcomes of bariatric surgery? A propensity score analysis in 464 patients. Obes Surg. 2019;29(9):2843–53.

    Article  Google Scholar 

  5. Horsley RD, Vogels ED, DAP MF, et al. Multimodal postoperative pain control is effective and reduces opioid use after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2018:394–400.

  6. Lam J, Suzuki T, Bernstein D, et al. An ERAS protocol for bariatric surgery: is it safe to discharge on post-operative day 1? Surg Endosc. 2019;33(2):580–6.

    Article  Google Scholar 

  7. Brethauer SA, Petrick A, Grieco A, et al. Employing new enhanced recovery goals for bariatric surgery (ENERGY): a Metabolic and Bariatric Surgery Accreditation and Quality Improvement (MBSAQIP) national quality improvement project. Surg Obes Relat Dis. 2018;14(11):S6.

    Article  Google Scholar 

  8. Kehlet H. Enhanced postoperative recovery: good from afar, but far from good? Anaesthesia. 2020;75(S1):e54–61.

    Article  Google Scholar 

  9. Kehlet H. ERAS implementation-time to move forward. Ann Surg. 2018;6:998–9.

    Article  Google Scholar 

  10. Baxter ALF, Watcha M, Baxter WV, et al. Development and validation of a pictorial nausea rating scale for children. Am Acad Pediatr. 2011;127(6):8.

    Google Scholar 

  11. Barkin RL, Vallejo RC, Wang V. Pharmacology of opioids in the treatment of chronic pain syndromes. Pain Physican. 2011;14:E343–60.

    Google Scholar 

  12. Center for Medicare and Medicaid Services. Opioid oral morphine milligram equivalent (MME) conversion factors. 2017. Available at: CMS%20Opioid-Morphine-EQ-Conversion-Factors-April-2017-CMS.pdf

  13. Gustafsson UO, Nygren J, Thorell A, et al. Pre-operative carbohydrate loading may be used in type 2 diabetes patients. Acta Anaesthesiol Scand. 2008;52(7):946–51.

    Article  CAS  Google Scholar 

  14. Bilku DK, Dennison AR, Hall TC, et al. Role of preoperative carbohydrate loading: a systematic review. Ann R Coll Surg Engl. 2014;96(1):15–22.

    Article  CAS  Google Scholar 

  15. Jibril F, Sharaby S, Mohamed A, et al. Intravenous versus oral acetaminophen for pain: systematic review of current evidence to support clinical decision-making. Can J Hosp Pharm. 2015;68(3):238–47.

    PubMed  PubMed Central  Google Scholar 

  16. Gong L, Thorn CF, Bertagnolli MM, et al. Celecoxib pathways: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics. 2012;22(4):310–8.

    Article  CAS  Google Scholar 

  17. Khan JS, Margarido C, Devereaux PJ, et al. Preoperative celecoxib in noncardiac surgery: a systematic review and meta-analysis of randomised controlled trials. Eur J Anaesthesiol. 2016;33(3):204–14.

    Article  CAS  Google Scholar 

  18. LYRICA (pregabalin)[package insert]Parke-Davis Div of Pfizer Inc. 2004. Available at: http://labeling.pfizer.com/showlabeling.aspx?id=561.

  19. Gajraj NM. Pregabalin: its pharmacology and use in pain management. Anesth Analg. 2007;105(6):1805–15.

    Article  CAS  Google Scholar 

  20. U.S. Food and Drug Administration. FDA In Brief: FDA requires new warnings for gabapentinoids about risk of respiratory depression. Available at: https://www.fda.gov/news-events/fda-brief/fda-brief-fda-requires-new-warnings-gabapentinoids-about-risk-respiratory-depression.

  21. Cavalcante AN, Sprung J, Schroeder DR, et al. Multimodal analgesic therapy with gabapentin and its association with postoperative respiratory depression. Anesth Analg. 2017;125(1):141–6.

    Article  CAS  Google Scholar 

  22. Lee S. Dexmedetomidine: present and future directions. Korean J Anesthesiol. 2019;72(4):323–30.

    Article  CAS  Google Scholar 

  23. Grape S, Kirkham KR, Frauenknecht J, et al. Intra-operative analgesia with remifentanil vs. dexmedetomidine: a systematic review and meta-analysis with trial sequential analysis. Anaesthesia. 2019;74(6):793–800.

    Article  CAS  Google Scholar 

  24. Mittal T, Dey A, Siddhartha R, et al. Efficacy of ultrasound-guided transversus abdominis plane (TAP) block for postoperative analgesia in laparoscopic gastric sleeve resection: a randomized single blinded case control study. Surg Endosc. 2018;32(12):4985–9.

    Article  Google Scholar 

  25. Becker DE. Nausea, vomiting, and hiccups: a review of mechanisms and treatment. Anesth Prog. 2010;57(4):150–7.

    Article  Google Scholar 

  26. Bakri MH, Ismail EA, Ibrahim A. Comparison of dexmedetomidine and dexamethasone for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Korean J Anesthesiol. 2015;68(3):254–60.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eyad Wohaibi.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

Bariatric ERAS protocols: pre-operative, intraoperative, and PACU phases (DOCX 29 kb)

ESM 2

Bariatric ERAS protocols: floor phase (DOCX 25 kb)

ESM 3

Summary of bariatric ERAS medication protocols by phase (DOCX 20 kb)

ESM 4

Bariatric ERAS pre-operative quality checklist (DOCX 266 kb)

ESM 5

Bariatric ERAS post-operative call checklist (DOCX 306 kb)

ESM 6

Bariatric ERAS post-operative patient questionnaire (DOCX 102 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Monte, S.V., Rafi, E., Cantie, S. et al. Reduction in Opiate Use, Pain, Nausea, and Length of Stay After Implementation of a Bariatric Enhanced Recovery After Surgery Protocol. OBES SURG 31, 2896–2905 (2021). https://doi.org/10.1007/s11695-021-05338-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-021-05338-5

Keywords

Navigation